Long Term Use of Hair Loss Medication

male pattern hair loss long term treatmentIt’s natural that many of our patients are so concerned by their hair loss that their priority is halting the hair loss and hopefully regrowing the thinning areas using a bespoke hair loss treatment programme. However, if the type of hair loss being treated is male pattern hair loss, there is no ‘cure’ as such, meaning that treatment must be sustained.

A long term solution

Happily, then, a hair loss treatment plan from Belgravia has no maximum time limit, and can be taken indefinitely. Indeed, many of our patients have seen great long term results spanning many years, where not only has excess shedding been halted, but thinning hair and receding hairlines have been regrown and then stabilised under treatment, just a take a look at our hair growth success stories blog for many examples.

A combined treatment programme containing the two medications that have been approved or licensed for treating hair loss by the UK and US medical regulatory bodies (the MHRA and the FDA) is the most effective means of treating hair loss medically.

The first of these medications, Propecia, is a daily oral tablet (containing 1mg finasteride) and works by blocking the production of DHT, a powerful androgen hormone formed by testosterone and the enzyme 5-alpha reductase. Propecia stops the follicular miniaturisation that occurs as a result of DHT, and can halt thinning and allow thick, healthy hair to regrow atop the scalp, therefore stopping a bald spot from appearing.

However, hair often needs a boost to regrow to its full potential, which is where the second medication, minoxidil can come in handy. Unlike Propecia, minoxidil is dose dependent, which means that a hair loss specialist is needed to ascertain the ideal daily strength for your individual case of hair loss.

Maintaining treatment

Belgravia produce a wide range of minoxidil formulations in their in-house pharmaceutical laboratory, ranging from liquids up to high strength minoxidil cream for particularly stubborn areas of hair loss.

Propecia and minoxidil are highly complementary, though it should be noted that if a patient discontinues the use of one medication, it cannot be expected that the remaining treatment will sustain all the hair regrowth and stabilisation of the other discontinued medication. If one or both medications are discontinued, those with pattern hair loss will notice “catch up loss,” where the hair that would have been shed if treatment had not been used falls out.

So, maintaining treatment is important, but different minoxidil strengths and formulations can be experimented with to ensure that hair regrowth is at its optimum level. There are also a number of hair growth boosters that patients have access to, and whilst these alone will not regrow hair, they can improve the condition of existing hair and regrowth. So, for a long term hair loss solution, a hair transplant is not your only option, and a medical approach may just save you money and the stress of an operation.

The Belgravia Centre—————————————————————————————————–

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. We offer clinically proven treatments for hair loss, as part of comprehensive treatment programmes offered by our hair loss specialists. Our in-house pharmacies produce high-strength medications for hair loss that contain medically proven ingredients and are available at no other clinic worldwide. Treatment programmes are available by visiting the centres or for home-use, anywhere in the UK or the rest of the world. View our hair loss success stories, which are the largest collection of such success stories in the world and demonstrate the levels of hair regrowth that so many of Belgravia’s patients achieve. You can also phone 0800 077 6666 for our hair loss helpline or to arrange a free consultation.

This entry was posted
on Monday, June 17th, 2013 at 5:12 pm and is filed under General Hair Loss, Hair Loss, Male Hair Loss.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.